Načítá se...
Drug treatment for facioscapulohumeral muscular dystrophy
BACKGROUND: Facioscapulohumeral muscular dystrophy is a progressive muscle disease which has no agreed treatment. Early suggestions that corticosteroids might be helpful were not supported by a subsequent open label study. The beta 2 adrenergic agonist albuterol, also known as salbutamol, is known t...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2004
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7003560/ https://ncbi.nlm.nih.gov/pubmed/15106171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002276.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|